Using flow cytometry measurements combined with quantitative analysis of cell cycle kinetics, we show that rhesus monkey embryonic stem cells (ESCs) are characterized by an extremely rapid transit through the G 1 phase, which accounts for 15% of the total cell cycle duration. Monkey ESCs exhibit a non-phasic expression of cyclin E, which is detected during all phases of the cell cycle, and do not growth-arrest in G 1 after ␥-irradiation, reflecting the absence of a G 1 checkpoint. Serum deprivation or pharmacological inhibition of mitogen-activated protein kinase kinase (MEK) did not result in any alteration in the cell cycle distribution, indicating that ESC growth does not rely on mitogenic signals transduced by the Ras/Raf/MEK pathway. Taken together, these data indicate that rhesus monkey ESCs, like their murine counterparts, exhibit unusual cell cycle features in which cell cycle control mechanisms operating during the G 1 phase are reduced or absent. STEM CELLS 2006;24:547-556 
INTRODUCTION
There is accumulating evidence that cell cycle control in mouse embryonic stem cells (ESCs) and somatic cells differs in that the mouse ESC cell cycle is not dependent on a functional p16 ink4a /cyclin D:cyclin-dependent kinase (Cdk) 4/retinoblastoma protein (pRB):E2F pathway [1] [2] [3] [4] [5] . Rather, the cyclin E:Cdk2 and cyclin A:Cdk2 complexes in ESCs are constitutively active throughout the cell cycle, suggesting that the mitotic cycle is constitutively primed for DNA replication [6] . Interestingly, mouse ESCs have a very short G 1 phase, ϳ1.5 hours, and they predominantly express the hyperphosphorylated form of the pRB (specific to the S and G 2 /M phases of the cell cycle) [7] , indicating that newly formed cells can enter a new phase of DNA replication very shortly after exit from mitosis. Another striking feature of the mitotic cycle of mouse ESCs is the lack of dependence on serum stimulation [8] and mitogen-activated protein kinase kinase (MEK)-associated signaling [4, 9, 10] . Mouse ESCs rely on phosphatidyl inositol-3 kinase (PI3K)-dependent signaling for progression through the G 1 phase [10] as well as for inhibition of differentiation [11] . However, PI3K activity is not dependent on persistent serum stimulation [10] but rather largely relies both on stimulation of the leukemia inhibitory factor (LIF) receptor and on expression of the ESC-specific Eras factor [12] . In addition, mouse ESCs do not undergo cell cycle arrest at the G 1 checkpoint in response to DNA damage or nucleotide depletion [13, 14] , although they synthetize abundant quantities of transcriptionally active p53 [13] . Taken together, these findings indicate that the mitotic cycle of ESCs largely escapes from external mitogenic stimuli and instead relies largely on intrinsic factors.
A crucial question is whether the unusual cell cycle characteristics of mouse ESCs are shared by primate ESCs. Here, we show that rhesus monkey ESCs display most of the cell cycle characteristics of mouse ESCs, including shortening of G 1 phase, non-phasic expression of cyclin E, predominance of hyperphosphorylated RB, lack of dependence on serum stimulation and MEK signaling, and absence of a DNA damage checkpoint in G 1 . We thus propose that these unique cell cycle characteristics are critical, and possibly universal, features of ESCs.
MATERIALS AND METHODS

Rhesus Monkey ESC Culture
Procedures for rhesus ESC line Oregon Monkey ES (ORMES)-1 and ORMES-6 cell cultures have been described previously [15] . Briefly, ORMES ESCs were grown at 37°C in 5% CO 2 atmosphere on mitotically inactivated mouse embryonic fibroblast (MEF) feeder cells in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA, http://www. invitrogen.com) supplemented with 20% fetal bovine serum (FBS; HyClone, Logan, UT, http://www.hyclone.com), 0.1 mM ␤-mercaptoethanol (Sigma, St. Louis, http://www.sigmaaldrich. com), 1% nonessential amino acids (Invitrogen), and 2 mM L-glutamine (Invitrogen). ESC colonies were passaged every 4 -5 days by treatment with 1 mg/ml collagenase IV (20 -30 minutes at 37°C), followed by mechanical dissociation.
PD98059 and U0126 (Sigma) were dissolved in dimethyl sulfoxide (Sigma) and added to the medium at a concentration of 25 and 10 M, respectively.
Lentiviral Vector Production and Infection of ESCs
R4SA-EFs-EGFP-W, a simian immunodeficiency virus (SIV)-
based vector, harbors the sequence encoding the enhanced Green Fluorescent Protein (eGFP) driven by the minimal version of the human elongation factor 1␣ promoter (EFs). It was generated by replacing the ClaI/XhoI restriction fragment containing the cytomegalovirus (CMV)-GFP cassette in pSIVgaMES4 [16] with a ClaI/SalI restriction fragment containing the EFs-eGFP cassette (a gift from Patrick Salmon). The method for producing SIV-based vectors in 293T cells is fully described elsewhere [17, 18] . Briefly, 293T cells were transfected with a mixture of DNAs containing 10 g of the pGRev plasmid encoding the vesicular stomatitis virus glycoprotein (VSV-G) envelope, 10 g of pSIV3 ϩ plasmid encoding the gag, pol, tat, and rev proteins, and 13 g of the R4SA-EFs-EGFP-W plasmid, using the calcium phosphate precipitation technique. The following day, cells were refed with 7 ml of DMEM and further cultured for 24 hours. The supernatant was then collected, cleared by centrifugation (3000 RPM, 15 minutes), and passed through a 0.8-M filter. Prior to infection, ORMES-1 cells were treated with 1 mg/ml collagenase IV for 3-5 minutes at 37°C. Clumps of undifferentiated ORMES-1 cells were isolated by mechanical dissociation and transferred to fresh medium (500 l) containing SIV-eGFP. Cells were incubated for 4 hours at 37°C before being replated on fresh feeder cells.
Time-Lapse Videomicroscopy Recording of Cell Division
ORMES-1 cells were grown in a 5% CO 2 atmosphere at 37°C for 4 -5 days in an incubating chamber (PeCon, Erbach, Germany, http://www.pecon.biz/pecon/index.htm) placed on a Leica DMIRBE inverted microscope stage (Leica, Heerbrugg, Switzerland, http://www.leica.com). Observations of individual eGFP ϩ cells were made with a 10ϫ objective under halogen illumination. Twenty fields were scanned per coverslip per hour using Metamorph software (Molecular Devices, Sunnyvale, CA, http://www.moleculardevices.com). Subsequent analysis of the movies allowed estimation of the cell cycle length of individual eGFP ϩ cells as measured by the time elapsed between two successive mitoses [19] .
Cell Cycle Kinetics Measurements
S phase and G 1 ϩG 2 ϩM phase durations can be derived from bromodeoxyuridine (BrdU) cumulative labeling experiments [20 -22] . Cumulative BrdU labeling was performed on ORMES cells grown on coverslips in 24-well plates in standard conditions. Forty-eight hours after plating, BrdU (20 g/ml) was added to the medium for the indicated times. Cells were fixed with 2% paraformaldehyde (PFA) and the labeling index (LI) values determined (proportion of BrdU ϩ cells [i.e., cells that were in S phase during BrdU exposure] with respect to the undifferentiated pool [i.e., the Oct-4 ϩ cell population]). Percentage of labeled mitosis (PLM) labeling [21] [22] [23] was used to determine the G 2 /M duration. Forty-eight hours after plating, cultures were pulse-labeled for 1 hour with BrdU (20 g/ml). For both procedures, three independent experiments were performed with the ORMES-1 cell line and two experiments with ORMES-6. Each time point was repeated on two sister coverlips. After survival periods, cultures were fixed in 2% PFA and processed for the detection of BrdU incorporation and Oct-4 expression. Cells were counterstained with Hoechst 33258 for 3 minutes to allow the identification of mitotic figures.
In Situ Immunofluorescence
ORMES cells were fixed in 2% PFA in phosphate-buffered saline (PBS) at 4°C for 1 hour. Immunohistochemistry was performed by a two-step procedure. Cells were permeabilized in Tris Buffer Saline (TBS) ϩ 0.2% Triton X-100, 0.1% Tween-20, for 20 minutes. Non-specific binding was blocked with 10% normal goat serum (Jackson ImmunoResearch Laboratories, West Grove, PA, http://www.jacksonimmuno.com) for 1 hour at room temperature (RT). To detect Oct-4 protein, cells were first incubated for 1 hour at 30°C with mouse monoclonal antibody anti-Oct-4 (C-10: sc5279) from Santa Cruz Biotechnology (Santa Cruz, CA, http://scbt.com) (1:1000 in DAKO-diluent). Cyclin E and cyclin A, respectively, were detected using C-19 (sc-198) and H-432 (sc-751) antibodies (1:100; Santa Cruz Biotechnology) incubated overnight at 4°C. Ki67 was detected using phycoerythrine-conjugated anti-human Ki67 monoclonal antibody (ref. no. 36525; BD Biosciences, San Diego, http:// www.bdbiosciences.com). After three rinses in TBS, cells were exposed either to affinity-purified goat anti-mouse or goat antirabbit immunoglobulin G (IgG) conjugated either to indocarbocyanine or to cyanin (Cy3 and Cy2, respectively; Jackson ImmunoResearch Laboratories) for 1 hour at RT followed by nuclear staining with 1 ng/ml Hoechst 33258 for 3 minutes. After three rinses in TBS, coverslips were mounted on slides. To detect both Oct-4 expression and bromodeoxyuridine (BrdU) incorporation, cells were first treated to reveal Oct-4 expression as described above. DNA was then denatured by incubation in 2N HCl, followed by a wash in a borate buffer (pH 8.5). Non-specific binding was blocked with 10% normal goat serum. BrdU incorporation was revealed by incubation with Alexa 488-conjugate anti-BrdU antibody (1:50 in DAKO-diluent) (Molecular Probes Inc., Eugene, OR, http://www.probes.invitrogen.com) for 2 hours at RT. Nuclei were counterstained with Hoechst 33258. Coverslips were examined using an oil objective microscope under UV light to detect fluorescein isothiocyanate (FITC) (filter 450 -490 nm), indocarbocyanine 3 (filter 550 -570 nm), and Hoechst 33258 (filter 355-425 nm). Coverslips were scanned at regular spacing with a grid corresponding to a field of 0.128 mm 2 . One hundred to 150 fields were observed per coverslip. Immunopositive cells were plotted onto a chart using the Mercator software (Explora Nova, La Rochelle, France, http://www.exploranova.com).
Flow Cytometric Analysis of Cell Cycle Distribution
Single-cell suspensions of ORMES cells were obtained by treatment with 1 mg/ml collagenase IV (37°C for 20 -30 minutes) followed by treatment with 0.1% trypsine (37°C for 3 minutes). For DNA content analysis, cells were fixed in 70% ethanol, rehydrated in PBS, treated for 30 minutes with RNase A (1 mg/ml) and for 5 minutes with propidium iodide (PI) (1 g/ml). Fluorescence intensity was determined by flow cytometry on a FACScan equipped with a 488-nm argon laser (Becton, Dickinson and Company, Franklin Lakes, NJ, http://www.bd.com). Data acquisition was performed with the CellQuest (Becton, Dickinson and Company) software, and the percentages of G 1 -, S-, and G 2 -phase cells were calculated with the MODFIT-LT software program (Verity Software House, Topsham, ME, http://www.vsh.com). To discriminate proliferating ORMES-1 cells from non-proliferating feeder cells, cultures were exposed to BrdU (20 g/ml) for 24 hours. Fresh medium containing BrdU was changed every 12 hours. Colonies were then dispersed into a single-cell suspension, fixed in 70% ethanol, and rehydrated in PBS. DNA denaturation was subsequently performed by incubation in 2N HCl followed by three washes in PBS containing 0.5% Tween and 0.5% bovine serum albumin (BSA) (PBT). Cells were then incubated with FITCconjugated anti-BrdU monoclonal antibody (1:50 in PBT; BD Biosciences) for 30 minutes at RT in the dark. After extensive washes in PBT, cells were incubated with 1 mg/ml RNase (20 minutes, RT) followed by PI treatment (1 g/ml) and analyzed as indicated above.
Western Blotting
Cells were lysed in 20 mM HEPES (pH 7.4), 100 mM NaCl, 50 mM NaF, 1% Triton X-100, 10% glycerol, 1 mM dithiothreitol, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, and a cocktail of protease inhibitors (Roche Diagnostics, Basel, Switzerland, http://www.roche-applied-science.com) for 1 hour at 4°C. Protein lysates were then cleared by centrifugation (14,000 RPM for 20 minutes). Total proteins (30 g) were electrophoresed on 10% SDS-polyacrylamide gel and electroblotted onto nitrocellulose membranes. For analysis of pRB expression, 2 ϫ 10 6 cells were lysed in 100 ml of 60 mM Tris-HCl (pH 6.8), 1.25% SDS, and 175 mM 2-Mercaptoethanol. Samples (30 l) were analyzed on 5% SDS polyacrylamide gel. After overnight treatment with blocking buffer (50 mM Tris-HCl [pH 7.6], 150 mM NaCl, 5% dry milk), the membranes were probed with anti-cyclin E (Sigma C4976), anti-cyclin A (Santa Cruz sc-751), or anti-pRB monoclonal antibodies (ref.
no. 554136; BD Biosciences). Blots were incubated with horseradish peroxidase-coupled anti-mouse, or anti-rabbit IgG, and developed using enzymatic chemiluminescence reagents (Amersham, Buckinghamshire, U.K., http://www.amersham.com).
RESULTS
Population Doubling Time and Cell Cycle Duration of the ORMES-1 ESCs
ORMES-1 cells were grown on mitotically inactivated MEF feeder cells in the presence of 20% FBS [15] . They were routinely seeded at a cell density of 0.3 ϫ 10 5 cells per cm 2 . Daily counts of cell numbers showed an initial moderate increase for the first 3 days (average doubling time, ϳ70 hours) (Fig. 1A) . Counts returned an average doubling time of approximately 25 hours during day 4 and 5. A negative binomial regression test performed in the R statistical computing environment (R Development Core Team, 2004) [24] revealed that there is a statistical difference in the growth rate between the periods of day 0 -3 and day 4 -5 (p Ͻ .05 for both growth curves), as indicated by the abrupt change in the slope of the growth curves at day 3. At days 6 and 7, cells reached confluency and population growth slowed, most likely as a consequence of cell death and higher rates of spontaneous differentiation.
To determine whether the variations in growth rates were paralleled by changes in the expression of pluripotency markers, colonies were immunolabeled to detect expression of the Oct-4 transcription factor (Fig. 1B, C) . At day 1, 69% Ϯ 22% (n ϭ 14) of cells within colonies expressed Oct-4. This percentage peaked at 99% Ϯ 1% (n ϭ 10) at day 3, to decline to 80% Ϯ 30% (n ϭ 10) at day 6. Therefore, all subsequent experiments were carried out on ORMES cells between day 3 and 5, which corresponds to the optimal growth phase, when 99% of cells express the pluripotency marker Oct-4. Within the ORMES colonies, 99% Ϯ 1% of Oct-4 ϩ cells were cycling cells, as shown by double immunolabeling against Ki67 and Oct-4 (Fig. 1D) .
Doubling time is a crude measure of proliferation rates and is contaminated with cell death and spontaneous differentiation. In order to accurately measure the mitotic cycle duration, we performed time-lapse videomicroscopy analysis on individual ORMES-1 cells. Cells were infected with SIV-eGFP, an SIVbased lentiviral vector expressing the eGFP, at a multiplicity of infection of 100 viruses per cell so as to transduce the eGFP gene into approximately 2%-3% of the cell population. Infected cells were propagated for 1 month and checked weekly for expression of eGFP by fluorescent microscopy. The fraction of eGFP-expressing cells did not vary with time, indicating identical rates of growth for infected and noninfected cells (data not shown).
Cells were grown on inactivated MEF. Four days after replating, the proliferative behavior of individual eGFP ϩ cells was recorded by time-lapse videomicroscopy during a 48-hour period. The time between two successive mitoses was calculated for 32 individual cells. As shown in Figure 2 , the cell cycle duration of individual ORMES-1 ranges from 12-21 hours (median value, 15 hours).
ORMES-1 ESCs Have an Unusual Cell Cycle Distribution
Next, we examined the distribution of ORMES-1 cells in cell cycle phases using single-color flow cytometry analysis after DNA staining with PI. Cells were harvested at day 4 of the culture, corresponding to the maximum growth rate (Fig. 1A) . To rule out a putative bias due to the presence of growthinactivated MEF, cultures were first incubated for 24 hours with 50 M BrdU in order to label all proliferating cells. Subsequent analysis of DNA content stained with PI was restricted to the BrdU ϩ cells (Fig. 3A, B) . Under these conditions, the fractions of G 1 , S, and G 2 /M phase cells were 16% Ϯ 3%, 56% Ϯ 3%, and 28% Ϯ 5%, respectively. ORMES-1 cells were induced to differentiate by withdrawal of MEF and culture on gelatinecoated dishes for 1 week. Under these conditions, the fractions of G 1 , S, and G 2 /M phase cells were 45% Ϯ 2%, 29% Ϯ 6%, and 26% Ϯ 5%, respectively (Fig. 3C) . Therefore, differentiation of ORMES-1 cells is accompanied by dramatic changes in the cell cycle distribution, characterized by a large increase in the proportion of cells in G 1 phase and a decrease in the proportion of cells in S phase.
Duration of Individual Phases of the Cell Cycle of ORMES-1 and ORMES-6 Cells
We investigated the duration of the individual phases of the cell cycle in undifferentiated, self-renewing ORMES-1 and ORMES-6 cells by combining the BrdU cumulative labeling technique [19, 20] with computation of the PLM [22, 23] . BrdU cumulative labeling is based on continuous BrdU exposure that leads to the incorporation of BrdU by successive cohorts of cycling cells progressing through S phase. The proportion of cells labeled by the BrdU exposure (LI) is monitored at regular intervals throughout the duration of T C -T S (T C , length of total cell cycle; T S , length of S phase). In this system, prolonged exposure to BrdU for periods equal to T C -T S returns LI values of 100% [21] . T G1ϩG2/M (length of G 1 ϩG 2/M phases) is determined by projecting the extrapolated 100% LI value onto the x-axis. Projection on the negative limb of the x-axis determines T S . So as to monitor the cell cycle of undifferentiated cells and to exclude spontaneously differentiating cells from the calculation, the LI was computed within the Oct-4 ϩ cell population (LI was calculated as the proportion of Oct4 ϩ cells that were labeled with BrdU). Three independent BrdU cumulative labeling experiments were performed on ORMES-1 cells (Fig. 4A) . Cu- So as to estimate the duration of G 2 /M (T G2/M ), the PLM method was implemented on sister cultures of the four independent experiments. After a 1-hour exposure to BrdU, the time interval required for 100% labeling of mitotic figures corresponds to the passage through G 2 and M (Fig. 4B) . So as to restrict the analysis to undifferentiated, self-renewing ORMES cells, the percentage of BrdU-labeled mitotic figures was calculated within the Oct-4 ϩ population. In ORMES-1 cells, this analytical procedure returned maximum values for G 2 /M of 9 (blue curve) to 10 hours (green curve). When T values are substracted from T G1ϩG2/M values of the same experiment, this indicates that T G1 is reduced, ranging from a few minutes (blue and green curves) to 1 hour (red curve). In ORMES-6 cells, the PLM method indicates that the maximum value of T G2/M is 7 hours, returning a T G1 of 3 hours (Fig. 4B) . These results show that the relative duration of G 1 phase with respect to T C is comprised between 10% and 20% in ORMES, as shown in the fluorescence-activated cell sorting (FACS) profile (Fig. 3B) .
DNA Damage Checkpoints in ORMES-1 Cells
To determine whether ORMES-1 cells have intact cell cycle response to DNA damage, we analyzed the effects of ␥-irradiation on the cell cycle. In somatic cells, DNA damage results in rapid decrease in the S-phase population, due to p53-and Cdc25A-dependent mechanisms that prevent G 1 cells with DNA damage from entering S phase [25] [26] [27] . As shown in Figure 5 , the G 1 -phase fraction in ESCs harvested 3-18 hours after exposure to 6 Grays of ionizing radiation decreased from 22% Ϯ 0.1% to 7% Ϯ 0.5%. In contrast, the G 2 -phase fraction increased from 36% Ϯ 1% to 70% Ϯ 2%. These results indicate that ORMES-1 ESCs do not have a functional DNA damage-response pathway for growth arrest in G 1 . By contrast, they exhibit growth arrest in the G 2 phase. Note that the fraction of cells in the G 1 phase in the nonirradiated cell population (22%) was larger than the fraction of G 1 cells found in the ESC population analyzed in Figure 3B (16%). The presence of feeder cells in the irradiation experiment largely accounts for this difference as the vast majority of feeder cells were in G 1 (data not shown).
Elevated Levels of Cyclins A and E Throughout the Cell Cycle in ORMES-1 Cells
We investigated cyclin E and cyclin A expression by immunoblot analysis. Undifferentiated ORMES-1 cells expressed high levels of cyclin A and cyclin E, and these levels decreased dramatically after differentiation induced by low-density culture in feeder-free conditions for 5 days (Fig. 6A) . To determine whether cyclin E and cyclin A levels fluctuate during cell cycle progression as observed in somatic cells or, alternatively, whether their expression is not cell cycle-dependent like in mouse ESCs [6] , cyclin E and cyclin A were analyzed by in situ immunofluorescence in the ORMES-1 cell population; 97% Ϯ 2% and 78% Ϯ 4% of Oct4 ϩ ORMES-1 cells expressed cyclin E and cyclin A, respectively (Fig. 6B, C) . By contrast, only a small fraction of differentiated Oct4 Ϫ ORMES cells expressed cyclin E (6% Ϯ 5%) and cyclin A (22% Ϯ 5%) (Fig. 6B, D) . Together, these data show that cyclin E is expressed throughout the cell cycle in ORMES-1 cells, indicating that its expression is not cell cycle-dependent. By contrast, not all Oct4 ϩ ORMES-1 cells expressed cyclin A, suggesting that cyclin A expression is downregulated in a subfraction of undifferentiated ORMES-1 cells. 
Predominence of Hyperphosphorylated pRB in ORMES-1 Cells
In parallel, phosphorylation of the retinoblastoma gene product (pRB) was investigated by immunoblot analysis. Mostly hyperphosphorylated pRB-specific to the S, G 2 , and M phases of the cell cycle-was detected in undifferentiated ORMES-1 cells, whereas hypophosphorylated, G 1 -specific, pRB was predominant in differentiated cells (Fig. 6E) . The predominance of hyperphosphorylated pRB in ORMES-1 cells reflects the cell cycle distribution of undifferentiated cells in which S and G 2 /M phases represent approximately 85% of the total cell cycle.
Dependency on Serum Stimulation and MEK Signaling for G 1 /S Transition in ORMES-1 Cells
We next addressed the question of whether rhesus monkey ESCs were dependent on persistent serum stimulation for progression in the cell cycle. After serum deprivation for 24 hours-a duration sufficient for every cell of the population to pass at least once through any serum checkpoint-no alteration was detected in the cell cycle distribution of ORMES-1 cells ( 2 test, p Ͼ .5), as shown by flow cytometry analysis (Fig. 7A) . Pairwise comparisons between control and serum-deprived sister cultures did not reveal significant variations in the percentages of cells in G 1 (p ϭ .5), in S (p ϭ .92), and in G 2 /M (p ϭ .89) (Student's t-test, 3 experiments) (Fig. 7B) .
Treatment of ORMES-1 cells for 24 hours with 25 M PD98059, or with 10 M U0126, to specifically inhibit MEK activity [28, 29] did not result in any significant alteration in the cell cycle distribution (PD09805-treated vs. control cells, (Fig. 7D) .
To confirm that MEK inhibition did not result in long-term alteration of the growth rate, ORMES-1 cells were propagated in the presence of PD98059, or with vehicle alone, for 7 days. Daily counts of cell numbers did not reveal a difference in growth rates between PD-treated and control cells (Fig. 7E) . Taken together, these data indicate that ORMES-1 cells do not require persistent mitogenic stimulation and functional MEK signaling to progress through the G 1 /S transition.
DISCUSSION
These results indicate that there are important similarities between murine and primate ESC cell cycle characteristics. Like their murine counterpart, rhesus monkey ESCs show a reduced G 1 phase, a predominance of hyperphosphorylated RB, an absence of DNA-damage checkpoint in G 1 , the absence of cell cycle-dependent expression of cyclin E, and lack of depen- Using the BrdU cumulative labeling technique, we estimated that the total cell cycle duration of ORMES-1 cells was 20 hours. This technique, when applied to heterogeneous cell populations cycling at different rates, predominantly returns the cell cycle duration of the slowest cycling cells [20] . Time-lapse videomicroscopy was therefore used to provide the range of the cell cycle duration values of individual ORMES-1 cells. This revealed that the population of ORMES-1 cells is heterogeneous with cells progressing through a complete cell cycle in a time window ranging from 12-21 hours. The reason ORMES-1 cells are heterogeneous in their cell cycle duration is unclear. It is unlikely to result from mutations that would heritably influence the cell cycle duration, because careful examination of the cell cycle durations of mother and daughter cells failed to reveal any positive correlation (data not shown). Interestingly, examination of the positions of eGFP-expressing mother and daughter cells revealed extensive movements within the colony. These movements are likely to modify the microenvironment, such as the accessibility of ESCs to extracellular matrix-associated cytokines provided by feeder cells. This could result in randomly influencing the cell cycle duration of individual ESCs.
The most striking feature of the murine ESC cell cycle, apart from being unusually rapid, is a short G 1 phase, which repre- sents approximately 15% of the total cell cycle duration, or 2 hours. The duration of the G 1 phase of mouse ESCs was calculated by measuring the delay between release from mitotic block and onset of [ 3 H]-thymidine incorporation in synchronized cells [7] . Conditions for propagating primate ESCs precluded large-scale amplification, which would be necessary to synchronize them by mitotic block. Therefore, we used an indirect method based on the combination of cumulative BrdU labeling and PLM to calculate the durations of the individual phases of the cell cycle in asynchronously growing cell populations. Despite monkey ESCs' having a total cell cycle duration up to twice as long as that of mouse ESCs, the relative duration of the G 1 phase is similar in the two species. In both species, the hyperphosphorylated form of pRB is predominant [7] , further indicating that the vast majority of the cells are in the S and the G 2 /M phases of the cell cycle. Taken together, these results indicate that a short G 1 -phase duration might be a common, and possibly universal, characteristic of ESCs, reflecting unique mechanisms of cell cycle control which have been conserved throughout vertebrate evolution. Cells of the embryonal carcinoma (EC) stem cell line P19 also display an unusually short G 1 phase [30] . Pluripotent EC stem cells can be induced to differentiate into mesodermal derivatives after treatment with retinoic acid (RA). Interestingly, upon synchronization by exposure to the reversible mitotic blocker, P19 EC cells were particularly vulnerable to RA while they progressed from mitosis to the next S phase and, by contrast, became resistant to RA-induced differentiation when they reached S phase [30] . These observations suggest that the G 1 phase corresponds to a window of increased sensitivity to differentiation signals. It is thus tempting to speculate that shortening the G 1 phase might shield pluripotent cells from activities that induce differentiation [22] .
Which mechanism, therefore, underlies the rapid transit through the G 1 phase in monkey ESCs? In mouse ESCs, there is compelling evidence that the G 1 3 S transition is not dependent on a functional cyclin D:Cdk4/6 3 RB:E2F pathway [1] [2] [3] [4] [5] and that rapid progression through the cell cycle relies largely, if not exclusively, on constitutively active cyclin E:Cdk2 and cyclin A:Cdk2 complexes [6] . Monkey ESCs also express cyclin E during all phases of the cell cycle, suggesting that ectopic cyclin E-Cdk2 kinase activity may also be a characteristic feature of primate ESCs. Interestingly, ORMES-1 cells did not express cyclin A in all phases of their cell cycle, in contrast to mouse ESCs [6] . Thus, mouse and monkey ESCs are likely to differ on the basis of the cell cycle-dependent regulation of cyclin A. The heterogenous cell cycle duration that characterizes rhesus ESCs could result from discontinuous expression of cyclin A in a subset of, or in all, Oct4 ϩ cells. Mouse ESCs fail to undergo cell cycle arrest in the G 1 phase in response to DNA damage [13] . Both mechanisms involved in DNA damage-dependent cell cycle arrest-the chk1/chk2 kinase-dependent degradation of the Cdc25A phosphatase [27] and the activation of the p53-p21 axis [31] -are not functional in mouse ESCs [14] . Here, we show that rhesus monkey ESCs are similarly impaired in their ability to respond to growth arrest in G 1 after treatment with ionizing radiation. Then the question arises as to how these cells maintain genomic integrity in the absence of a G 1 checkpoint. After DNA damage, both mouse and rhesus ESCs undergo apoptosis ( [13] and our unpublished data), suggesting that the function of p53 in ESCs is to trigger apoptosis in order to efficiently eliminate cells with damaged DNA. An alternative mechanism was recently suggested in mouse ESCs in which, after DNA damage, transcriptionally active p53 repressed the activity of the nanog promoter and irreversibly induced differentiation, thus eliminating DNA-dam- (dotted line), or in vehicle alone (plain line), for 7 days. Cell numbers were counted using a trypan blue exclusion assay at the indicated time points. Means Ϯ SEM were calculated from two replicates. Abbreviations: DMSO, dimethyl sulfoxide; FBS, fetal bovine serum; MEK, mitogen-activated protein kinase kinase; ns, non significant; ORMES, Oregon Monkey ES; PI, propidium iodide.
aged cells from the pool of undifferentiated stem cells [32] . Whether a similar mechanism operates in primate ESCs remains to be determined.
We show that rhesus monkey ESCs, like their murine counterpart [8, 10] , do not rely on persistent serum stimulation for cell cycle progression. Notably, serum was withdrawn for 24 hours, thus allowing all cells to progress through any serumdependent checkpoint regardless of their position in the cell cycle at the onset of serum withdrawal. These data indicate that rhesus monkey ESCs can efficiently progress through the G 1 -to-S phase transition in the absence of mitogenic signals. Rhesus monkey ESCs also appear not to be sensitive to pharmacological inhibition of MEK, a property shared with mouse ESCs [10, 33, 34] . In the mouse, inhibition of MEK-dependent signaling facilitates self-renewal [33] by sustaining expression of Oct-4 [34] . It remains to be determined whether a similar mechanism operates in primate ESCs.
CONCLUSION
Our results show that rhesus monkey ESCs share several fundamental properties of the cell cycle with mouse ESCs. We propose that these unique properties, which are distinct from those of other mammalian non-transformed cell types, are fundamental characteristics of ESCs. In view of the present results, together with several reports pointing to common mechanisms in cell cycle regulation of mouse ESCs and other pluripotent cell types such as the pluripotent cells of the mouse epiblast [35] , the epiblast-like cells [6] , the P19 EC cells [36, 37] , and the embryonic germ cells [38] , we hypothesize that these unique cell cycle characteristics of ESCs may contribute to stemness. 
